Pirlimycin
Pirlimycin, a lincosamide antibiotic, is active against Gram-positive bacteria. Pirlimycin acts by inhibiting bacterial protein synthesis via binding with the 50S subunit of the ribosome[1].
Product Specifications
CAS Number
79548-73-5
UNSPSC
12352005
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pirlimycin.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H]1C[C@@H](CCN1)CC)N[C@]([C@@]2([H])O[C@@H]([C@H](O)[C@@H](O)[C@H]2O)SC)([H])[C@@H](Cl)C
Molecular Formula
C17H31ClN2O5S
Molecular Weight
410.96
References & Citations
[1]Birkenmeyer RD, et, al. Synthesis and antimicrobial activity of clindamycin analogues: pirlimycin, 1,2 a potent antibacterial agent. J Med Chem. 1984 Feb;27 (2) :216-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8432240-02 5x 0.002 mg
Human I-309 Recombinant Protein Lyophilized
Sign In for Pricing
View Details